歐 穎謙

Medicine & Life Sciences

1. Botulinum Toxins 75%
2. Urinary Tract 63%
3. Urinary Bladder 55%
4. Injections 46%
5. Spinal Cord Injuries 40%
6. Ureteral Neoplasms 34%
7. Carcinoma 30%
8. Urinary Incontinence 29%
9. Underactive Urinary Bladder 26%
10. Urodynamics 23%
11. Therapeutic Uses 22%
12. Overactive Urinary Bladder 20%
13. Renal Cell Carcinoma 20%
14. Cell- and Tissue-Based Therapy 20%
15. Therapeutics 18%
16. Monocytes 17%
17. Necrosis 16%
18. Stem Cells 15%
19. Lymphocytes 14%
20. Elderly 14%
21. Randomized Controlled Trials 14%
22. Exercise 13%
23. Urine 13%
24. Cell Line 12%
25. Population 12%
26. Quality of Life 11%
27. Erlotinib Hydrochloride 10%
28. Neoplasms 10%
29. Control Groups 8%
30. Diaries 8%
31. Exosomes 8%
32. ErbB Receptors 8%
33. Kidney 7%
34. Lower Urinary Tract Symptoms 7%
35. Referral and Consultation 7%
36. Safety 6%
37. Muscles 6%
38. Mesenchymal Stem Cells 6%
39. Prostaglandin Receptors 6%
40. Multivariate Analysis 6%
41. Ataxia 5%
42. In Vitro Techniques 5%
43. ROC Curve 5%
44. Everolimus 5%